Successful transplant of porcine heart into adult human with end-stage heart disease
Written by Charlie King | 15 Jan 2022
In a first-of-its-kind surgery, a 57-year-old patient with terminal heart disease received a successful transplant of a genetically-modified pig heart and is still doing well three days later…. read more.
Adult epilepsy treatment reduces seizures in children
Written by Charlie King | 15 Jan 2022
Seizures were reduced in children as young as 3 who received responsive neurostimulation. A surgical treatment commonly used to reduce epileptic seizures in adults also is effective and… read more.
New real-world data show high rate of patient adherence to Tepezza for thyroid eye disease (TED) – Horizon Therapeutics
Written by Charlie King | 14 Jan 2022
Horizon Therapeutics plc announced findings of a real-world adherence analysis of Tepezza for the treatment of TED ( Thyroid Eye Disease) at the American Academy of Ophthalmology Annual… read more.
EMA gets a budget boost
Written by Gary Finnegan | 14 Jan 2022
The EU drug regulator, the European Medicines Agency (EMA), has a beefed-up budget for 2022 and plans to grow further in the years ahead. The watchdog’s Management Board… read more.
Can a dangerous microbe offer a new way to silence pain?
Written by Charlie King | 13 Jan 2022
Deadly anthrax toxin blocks multiple types of pain in mice, study shows. Anthrax has a scary reputation. Widely known to cause serious lung infections in humans and unsightly,… read more.
EU backs new COVID-19 treatments
Written by Gary Finnegan | 13 Jan 2022
The European Medicines Agency (EMA) has authorised several new therapies and vaccines for COVID-19 which offer fresh hope of containing the two-year old pandemic, the EU drug watchdog… read more.
Spicy breast milk?
Written by Charlie King | 12 Jan 2022
Breast milk is the first food that babies consume. Various studies have suggested that the “taste experience” in early childhood influences eating behavior in adults. Unlike standardized infant… read more.
EMA approved 91 products in 2021
Written by Gary Finnegan | 12 Jan 2022
Thirteen new medicines were given the green light at the December meeting of the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP). This brings to… read more.
Parkinson’s protein blueprint could help fast-track new treatments
Written by Charlie King | 11 Jan 2022
Researchers have solved a decade-long mystery about a critical protein linked to Parkinson’s disease that could help to fast-track treatments for the incurable disease. The research, published in Nature,… read more.
Memory T cells from previous common cold infections protect against infection with SARS-CoV-2
Written by Charlie King | 11 Jan 2022
A new study, published in Nature Communications confirms what many people have suspected for a long time – namely that previous human coronavirus infection e.g. with the common cold, could… read more.
Are hedgehogs to blame for superbugs?
Written by Gary Finnegan | 10 Jan 2022
The threat of antimicrobial resistance (AMR), whereby antibiotics not longer work well on bacterial illness, is a slow-burning pandemic with the potential to eclipse even the worst of… read more.
School closures improved sleep for teenagers
Written by Gary Finnegan | 10 Jan 2022
The closure of schools in spring 2020 had a negative effect on the health and well-being of many young people. But home-schooling also had a positive flipside for… read more.
Subscribe for our mailing list
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
This website uses cookies to enhance your browsing experience, analyse site traffic, and personalise content. By clicking “Accept” you consent to the use of all cookies. You can manage your preferences or withdraw consent at any time by visiting our cookie settings.
Functional Always active
Preferences
Statistics
Marketing
If you’re a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
